- Home
- ARBEW vs BRTX Comparison
ARBEW vs BRTX Comparison
Compare ARBEW & BRTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ARBEW | BRTX |
|---|---|---|
| Founded | 2015 | 1997 |
| Country | Israel | United States |
| Employees | 144 | N/A |
| Industry | EDP Services | Managed Health Care |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | N/A | 9.7M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | ARBEW | BRTX |
|---|---|---|
| Price | $0.14 | $1.13 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 32.4K | ★ 79.2K |
| Earning Date | 03-05-2025 | 11-12-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $768,000.00 | $383,400.00 |
| Revenue This Year | N/A | $112.14 |
| Revenue Next Year | N/A | $139.81 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 1.70 |
| 52 Week Low | $0.13 | $0.98 |
| 52 Week High | $1.25 | $2.55 |
Technical Indicators
Market Signals| Indicator | ARBEW | BRTX |
|---|---|---|
| Relative Strength Index (RSI) | 35.38 | 45.56 |
| Support Level | $0.14 | $1.00 |
| Resistance Level | $0.24 | $1.16 |
| Average True Range (ATR) | 0.03 | 0.08 |
| MACD | -0.00 | 0.02 |
| Stochastic Oscillator | 0.00 | 89.24 |
Price Performance
Historical ComparisonAbout ARBEW Arbe Robotics Ltd. Warrant
Arbe Robotics Ltd is a provider of 4D Imaging Radar solutions enabling driver-assist systems while paving the way for fully autonomous driving. It is a research and development company in the field of chips for Advanced radar systems, which are mainly intended to be used as Advanced Driver Assistance Systems (ADAS) adapted for autonomous vehicles as well as for non-automotive uses. Its geographical segments include Sweden, China, Germany, Hong Kong, USA, Israel, Switzerland, Italy, and others.
About BRTX BioRestorative Therapies Inc. (NV)
BioRestorative Therapies Inc is a biotechnology company based in the United States. It focuses on the development of regenerative medicine products and therapies using cell and tissue protocols, involving adult (non-embryonic) stem cells. The company's two core development programs include the Disc/Spine Program, which involves cell therapy candidate, BRTX-100, a product formulated from autologous cultured mesenchymal stem cells collected from the patient's bone marrow; and the Metabolic Program, which includes the development of cell-based therapy to target obesity and metabolic disorders using brown adipose-derived stem cells, to generate brown adipose tissue.